IP Library › Granted Patent US 11,981,941
Granted Patent B2
US 11,981,941 · App. 18/168,096 · Granted May 14, 2024

Polypeptides

Inventors: Morten Gjermansen (Greve, DK); Klaus Gori (Copenhagen, DK); Henrik Marcus Geertz-Hansen (Copenhagen, DK); Jesper Salomon (Holte, DK); Thomas Holberg Blicher (Copenhagen, DK); Nikolaj Spodsberg (Holte, DK)
Assignee: NOVOZYMES A/S
C12N9/22C11D3/2065C11D3/22C11D3/3707C11D3/38627C11D3/38636C11D3/38681C12Y301/21C12Y301/21001C11D2111/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,981,941
App. No.
18/168,096
Granted
May 14, 2024
Kind
B2
Abstract

The present invention relates to polypeptides, nucleotides encoding the polypeptide, as well as methods of producing the polypeptides. The present invention also relates to detergent composition comprising polypeptides, a laundering method and the use of polypeptides.

Claims (18)

1. A polynucleotide encoding a polypeptide having DNase activity, wherein the polypeptide comprises the motif HXXP (SEQ ID NO: 210), where H is histidine, P is proline and X is any amino acid and comprises one or both of the motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 204) or ASXNRSKG (SEQ ID NO: 205), and wherein the polypeptide has at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 21.

2. A nucleic acid construct or expression vector comprising the polynucleotide of claim 1 operably linked to one or more control sequences that direct the production of the polypeptide in an expression host.

3. A recombinant host cell comprising the polynucleotide of claim 1 operably linked to one or more control sequences that direct the production of the polypeptide.

4. A method of producing a polypeptide having DNase activity, comprising:

(a) cultivating the recombinant host cell of claim 3 under conditions conducive for production of the polypeptide; and

(b) recovering the polypeptide.

5. The method of claim 4 , wherein the polypeptide having DNase activity has at least 85% sequence identity to the amino acid sequence of SEQ ID NO: 21.

6. The method of claim 4 , wherein the polypeptide having DNase activity has at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 21.

7. The method of claim 4 , wherein the polypeptide having DNase activity has at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 21.

8. The method of claim 4 , wherein the polypeptide having DNase activity has at least 97% sequence identity to the amino acid sequence of SEQ ID NO: 21.

9. The method of claim 4 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 21.

10. The method of claim 4 , wherein the recombinant host cell comprises more than one copy of a polynucleotide.

11. The method of claim 4 , wherein the recombinant host cell is a Gram-positive bacterium selected from the group consisting of Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus , and Streptomyces.

12. The method of claim 4 , wherein the recombinant host cell is a Bacillus host cell.

13. The method of claim 4 , wherein the recombinant host cell is a filamentous fungal host cell selected from the group consisting of Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Flumicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phlebia, Piromyces, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trametes , and Trichoderma.

14. The method of claim 4 , wherein at least one of the one or more control sequences is foreign to the polynucleotide.

15. The method of claim 4 , wherein the polynucleotide is heterologous to the recombinant host cell.

16. The method of claim 4 , wherein the polypeptide is heterologous to the recombinant host cell.

Priority Claims (3)
DK PA 2015 00615 · Oct 7, 2015 · national
DK PA 2015 00617 · Oct 7, 2015 · national
DK PA 2015 00618 · Oct 7, 2015 · national
Continuity (3)
Division 17157137 · Jan 25, 2021
Division 15766894
Related Publication 20240067943A1 · Feb 29, 2024